Scientists test new 'Cancer Spotlight' tracer in patients
NCT ID NCT03164486
Summary
This early-phase study is testing a new radioactive tracer called 18F-αvβ6-BP to see if it can help doctors better locate cancers in the body using PET scans. The study involves 27 patients with breast, colorectal, lung, or pancreatic cancer. Researchers will inject the tracer and perform multiple scans to see where it accumulates and check for safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of California Davis Comprehensive Cancer Center
Sacramento, California, 95817, United States
Conditions
Explore the condition pages connected to this study.